Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 196

Results For "Director"

2211 News Found

Sun Pharma introduces treatment for plaque psoriasis in Canada
Drug Approval | October 28, 2021

Sun Pharma introduces treatment for plaque psoriasis in Canada

Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return


Sanofi India PAT at Rs. 529.8 cr in Q3CY21
News | October 27, 2021

Sanofi India PAT at Rs. 529.8 cr in Q3CY21

The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021


Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
Diagnostic Center | October 27, 2021

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21


Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity
Biotech | October 26, 2021

Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity

Support from DFC will help produce one billion vaccine doses by the end of 2022


Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
News | October 25, 2021

Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22

The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively


Fujifilm AI detects Covid-19 Pneumonia
Digitisation | October 22, 2021

Fujifilm AI detects Covid-19 Pneumonia

Fujifilm India recently introduced a “Covid-19 Pneumonia Image Analysis Program” that helps in diagnosing chest CT images that helps in findings of Covid-19 pneumonia


Jubilant Pharmova consolidated PAT at Rs. 142.84 cr. in Q2FY22
News | October 22, 2021

Jubilant Pharmova consolidated PAT at Rs. 142.84 cr. in Q2FY22

The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment


Global Heart Hub and Novartis partner to tackle ASCVD
Public Health | October 21, 2021

Global Heart Hub and Novartis partner to tackle ASCVD

Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care


U.S. FDA gives green light to Moderna and J&J booster doses
Drug Approval | October 21, 2021

U.S. FDA gives green light to Moderna and J&J booster doses

The authority also allowed mix and match of booster doses once the primary vaccine has been administered.


Ivenix selects Eastman Tritan copolyester for its new infusion system
Medical Device | October 21, 2021

Ivenix selects Eastman Tritan copolyester for its new infusion system

Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections